Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 19 | 2026 | 760 | 4.950 |
Why?
|
| Genetic Therapy | 23 | 2026 | 852 | 4.680 |
Why?
|
| Genetic Vectors | 21 | 2026 | 929 | 4.560 |
Why?
|
| Gene Editing | 4 | 2026 | 331 | 1.160 |
Why?
|
| Glycogen Storage Disease Type II | 2 | 2018 | 8 | 1.070 |
Why?
|
| alpha-Glucosidases | 2 | 2018 | 10 | 1.070 |
Why?
|
| Capsid Proteins | 2 | 2026 | 107 | 0.990 |
Why?
|
| Immunodominant Epitopes | 1 | 2026 | 59 | 0.930 |
Why?
|
| Viral Tropism | 1 | 2026 | 55 | 0.920 |
Why?
|
| CRISPR-Cas Systems | 4 | 2026 | 369 | 0.910 |
Why?
|
| Gene Transfer Techniques | 5 | 2024 | 325 | 0.900 |
Why?
|
| Capsid | 1 | 2026 | 104 | 0.880 |
Why?
|
| Immune System Diseases | 1 | 2022 | 19 | 0.700 |
Why?
|
| Muscle, Skeletal | 5 | 2026 | 788 | 0.690 |
Why?
|
| Transduction, Genetic | 6 | 2026 | 242 | 0.680 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 113 | 0.650 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 100 | 0.650 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 2019 | 13 | 0.510 |
Why?
|
| Mitochondrial Diseases | 2 | 2019 | 21 | 0.500 |
Why?
|
| Muscular Diseases | 2 | 2019 | 51 | 0.490 |
Why?
|
| Transgenes | 4 | 2026 | 207 | 0.490 |
Why?
|
| Corpus Striatum | 1 | 2016 | 98 | 0.470 |
Why?
|
| Animals | 18 | 2026 | 21449 | 0.460 |
Why?
|
| Lung Diseases | 2 | 2017 | 183 | 0.430 |
Why?
|
| Huntington Disease | 1 | 2016 | 164 | 0.430 |
Why?
|
| Central Nervous System | 4 | 2024 | 200 | 0.420 |
Why?
|
| MicroRNAs | 2 | 2021 | 714 | 0.410 |
Why?
|
| RNA Interference | 1 | 2017 | 647 | 0.400 |
Why?
|
| Mice | 14 | 2026 | 11171 | 0.390 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2017 | 42 | 0.380 |
Why?
|
| Tay-Sachs Disease | 2 | 2025 | 55 | 0.380 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2023 | 46 | 0.380 |
Why?
|
| Neurons | 2 | 2023 | 935 | 0.360 |
Why?
|
| Sudden Infant Death | 1 | 2012 | 29 | 0.360 |
Why?
|
| Lung | 1 | 2017 | 969 | 0.350 |
Why?
|
| Humans | 21 | 2026 | 65630 | 0.340 |
Why?
|
| Gangliosidosis, GM1 | 2 | 2026 | 26 | 0.340 |
Why?
|
| beta-Galactosidase | 2 | 2026 | 84 | 0.340 |
Why?
|
| Immunity, Innate | 3 | 2025 | 829 | 0.300 |
Why?
|
| Glycogen | 2 | 2018 | 40 | 0.270 |
Why?
|
| Dermis | 1 | 2026 | 22 | 0.240 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2019 | 8 | 0.240 |
Why?
|
| RNA, Messenger | 2 | 2026 | 1580 | 0.230 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2026 | 25 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 18 | 0.230 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 38 | 0.220 |
Why?
|
| Liver | 3 | 2022 | 874 | 0.220 |
Why?
|
| Gene Expression | 3 | 2019 | 854 | 0.210 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 105 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 2319 | 0.210 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 57 | 0.200 |
Why?
|
| Fibroblasts | 1 | 2026 | 423 | 0.200 |
Why?
|
| Dystrophin | 1 | 2023 | 30 | 0.200 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2024 | 91 | 0.200 |
Why?
|
| Lipids | 1 | 2026 | 329 | 0.200 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2024 | 70 | 0.200 |
Why?
|
| Skin | 1 | 2026 | 436 | 0.190 |
Why?
|
| T-Lymphocytes | 2 | 2025 | 1010 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 96 | 0.180 |
Why?
|
| Immune Tolerance | 1 | 2022 | 186 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 107 | 0.160 |
Why?
|
| Gene Targeting | 1 | 2021 | 77 | 0.160 |
Why?
|
| Endonucleases | 1 | 2021 | 84 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 182 | 0.160 |
Why?
|
| Lentivirus | 2 | 2017 | 64 | 0.160 |
Why?
|
| Nanoparticles | 1 | 2026 | 551 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 222 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2021 | 239 | 0.150 |
Why?
|
| Huntingtin Protein | 2 | 2016 | 151 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1291 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2019 | 180 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2019 | 233 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2023 | 2168 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2018 | 391 | 0.130 |
Why?
|
| Gammaretrovirus | 1 | 2017 | 9 | 0.130 |
Why?
|
| Methacholine Chloride | 1 | 2017 | 23 | 0.130 |
Why?
|
| Potassium Chloride | 1 | 2017 | 15 | 0.130 |
Why?
|
| Oncolytic Viruses | 1 | 2017 | 10 | 0.130 |
Why?
|
| Extracellular Space | 1 | 2017 | 29 | 0.130 |
Why?
|
| Albuterol | 1 | 2017 | 24 | 0.130 |
Why?
|
| Antigens, CD19 | 1 | 2017 | 25 | 0.130 |
Why?
|
| Drug Approval | 1 | 2017 | 28 | 0.130 |
Why?
|
| Carnitine | 2 | 2019 | 19 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 154 | 0.130 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2016 | 9 | 0.120 |
Why?
|
| Adenoviridae | 1 | 2017 | 132 | 0.120 |
Why?
|
| Bronchi | 1 | 2017 | 86 | 0.120 |
Why?
|
| Trachea | 1 | 2017 | 83 | 0.120 |
Why?
|
| Trinucleotide Repeats | 1 | 2016 | 20 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 138 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 897 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 95 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 462 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 115 | 0.120 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 312 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2017 | 209 | 0.120 |
Why?
|
| Calcium Signaling | 1 | 2017 | 164 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 223 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 281 | 0.110 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 225 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 372 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 3500 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2017 | 274 | 0.110 |
Why?
|
| Infant | 2 | 2025 | 1710 | 0.100 |
Why?
|
| Prognosis | 1 | 2018 | 1791 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2021 | 3328 | 0.100 |
Why?
|
| Immunoglobulin E | 2 | 2010 | 81 | 0.090 |
Why?
|
| Hypersensitivity | 2 | 2010 | 73 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2026 | 5818 | 0.090 |
Why?
|
| Peptides | 1 | 2015 | 593 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 517 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2012 | 292 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2010 | 63 | 0.080 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 81 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2026 | 2074 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 986 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2009 | 37 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2010 | 209 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2009 | 101 | 0.070 |
Why?
|
| Male | 6 | 2026 | 31281 | 0.070 |
Why?
|
| Phenotype | 1 | 2012 | 1235 | 0.070 |
Why?
|
| Cytokines | 1 | 2010 | 964 | 0.060 |
Why?
|
| G(M1) Ganglioside | 1 | 2026 | 12 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2026 | 35 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2026 | 46 | 0.060 |
Why?
|
| Child | 2 | 2026 | 4632 | 0.060 |
Why?
|
| Liposomes | 1 | 2026 | 117 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 20 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2026 | 193 | 0.060 |
Why?
|
| Armadillo Domain Proteins | 1 | 2023 | 27 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2023 | 122 | 0.050 |
Why?
|
| Axons | 1 | 2023 | 124 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 188 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 204 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 117 | 0.050 |
Why?
|
| Mutation | 1 | 2010 | 2670 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 104 | 0.040 |
Why?
|
| Female | 4 | 2026 | 34293 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 180 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2026 | 2496 | 0.040 |
Why?
|
| Immune System | 2 | 2010 | 132 | 0.040 |
Why?
|
| Binding Sites | 1 | 2021 | 917 | 0.040 |
Why?
|
| Brain | 1 | 2026 | 1618 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1226 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 301 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 91 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 104 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 193 | 0.030 |
Why?
|
| Gangliosides | 1 | 2015 | 19 | 0.030 |
Why?
|
| Brain Stem | 1 | 2015 | 30 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 754 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6348 | 0.030 |
Why?
|
| Astrocytes | 1 | 2015 | 123 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 210 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 503 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 2029 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 20 | 0.020 |
Why?
|
| Aspergillus | 1 | 2010 | 10 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2009 | 19 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2009 | 93 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 476 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 149 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 449 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 664 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 584 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 17507 | 0.010 |
Why?
|